Show simple item record

dc.contributor.authorWuketich, Stefan
dc.contributor.authorHienz, Stefan
dc.contributor.authorMarosi, Christie
dc.date.accessioned2017-05-03T13:14:33Z
dc.date.available2017-05-03T13:14:33Z
dc.date.issued2012
dc.date.modified2014-07-22T04:28:59Z
dc.identifier.issn0941-4355
dc.identifier.doi10.1007/s00520-011-1107-y
dc.identifier.urihttp://hdl.handle.net/10072/61521
dc.description.abstractPurpose Chemotherapy-induced oral mucositis (CIOM) is a common side effect of cancer therapy that may lead to significant morbidity and interfere with the treatment plan. The present prospective, cross-sectional study intended to describe the prevalence of clinically relevant CIOM (CRCIOM) in outpatients receiving chemotherapy for solid tumors. Methods Intra-oral assessments were performed on 298 consecutively recruited patients, who had undergone at least 14 days of chemotherapy for solid tumors in our outpatient oncology department. The presence of CIOM was evaluated using the Oral Mucositis Assessment Scale. CRCIOM was defined as the presence of ulcers (=1 cm2), severe erythema, and/or inability to eat solid foods (WHO grades 2-4). Furthermore, the current levels of oral hygiene and oral health were measured. Results A low prevalence (18 patients, 6%) of CRCIOM was found in the investigated patient collective, including 1% of patients with severe (WHO grade 3/4) CIOM. In the CRCIOM group, 16 patients were male, and two were female; 8 patients with CRCIOM had received head and neck radiotherapy. A higher prevalence of CRCIOM was found in smoking patients (12.7% vs. 4.5%, p?<?0.05) and in the patients who have not had a dental checkup within the preceding 12 months (11.2% vs. 3.0%, p? <?0.01). Diabetes mellitus and low WBC appeared not to be associated with higher CRCIOM rates. The plaque and gingival indexes were significantly increased (p?<?0.01) in the CRCIOM group. Conclusions Although CRCIOM was a rare event in the investigated patient population, our results emphasize that pre-treatment dental therapy and primary preventive measures (including oral hygiene instructions) can be improved. Before starting chemotherapy, increased awareness of individual risk factors, such as male sex, tobacco smoking, low dental checkup frequency, poor oral hygiene, and a reduced oral health status, could help to prevent CRCIOM.
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.languageEnglish
dc.language.isoeng
dc.publisherSpringer
dc.publisher.placeGermany
dc.relation.ispartofstudentpublicationN
dc.relation.ispartofpagefrom175
dc.relation.ispartofpageto183
dc.relation.ispartofjournalSupportive Care in Cancer
dc.relation.ispartofvolume20
dc.rights.retentionY
dc.subject.fieldofresearchMedical and Health Sciences not elsewhere classified
dc.subject.fieldofresearchPsychology and Cognitive Sciences not elsewhere classified
dc.subject.fieldofresearchMedical and Health Sciences
dc.subject.fieldofresearchPsychology and Cognitive Sciences
dc.subject.fieldofresearchcode119999
dc.subject.fieldofresearchcode179999
dc.subject.fieldofresearchcode11
dc.subject.fieldofresearchcode17
dc.titlePrevalence of clinically relevant oral mucositis in outpatients receiving myelosuppressive chemotherapy for solid tumors
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.hasfulltextNo Full Text
gro.griffith.authorHienz, Stefan


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record